Synthesis and Characterization of a Novel Prostate Cancer-Targeted Phosphatidylinositol-3-Kinase Inhibitor Prodrug

Journal of Medicinal Chemistry - United States
doi 10.1021/jm300881a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Cloning of a Novel Phosphatidylinositol Kinase-Related Kinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling

Clinical Cancer Research
Cancer ResearchOncology
2012English

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Characterization of the Met326Ile Variant of Phosphatidylinositol 3-Kinase P85

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

Treatment of Multiple Myeloma With VLA4-targeted Nanoparticles Delivering Novel C-Myc Inhibitor Prodrug

2012English

Phosphatidylinositol-3-Kinase Pathway

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Synthesis and Characterization of a Novel Liver-Targeted Prodrug of Cytosine-1-B-D-Arabinofuranoside Monophosphate for the Treatment of Hepatocellular Carcinoma

English

Mouse P170 Is a Novel Phosphatidylinositol 3-Kinase Containing a C2 Domain

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy